Evaluating the efficacy and safety of oral triple sequential combination therapy for treating patients with pulmonary arterial hypertension: A multicenter retrospective study

Evaluating the efficacy and safety of oral triple sequential combination therapy for treating patients with pulmonary arterial hypertension: A multicenter retrospective study

Abstract This study aimed to evaluate the effectiveness and safety of an oral sequential triple combination therapy with selexipag after dual combination therapy with endothelin receptor antagonist (ERA) and phosphodiesterase‐5 inhibitor (PDE5I)/riociguat in pulmonary arterial hypertension (PAH) pat...

Full description

Bibliographic Details
Main Authors: Qin‐Hua Zhao, Jun Chen, Fa‐Dong Chen, Hong‐Yun Ruan, Wei Zhang, Yan‐Li Zhou, Qi‐Qi Wang, Xiao‐Ling Xu, Ke‐Fu Feng, Jian‐Zhou Guo, Su‐Gang Gong, Rui‐Feng Zhang, Lan Wang
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Pulmonary Circulation
Subjects:
event
oral sequential triple combination therapy
pulmonary arterial hypertension
risk stratification
survival
Online Access:https://doi.org/10.1002/pul2.12351

Internet

https://doi.org/10.1002/pul2.12351

Similar Items